Health

Results: 1477-1488 of 8134

PR Newswire associated0

Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programmes

Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study

Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions

PR Newswire associated0

Olympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio

Implantica Successfully Completes MDSAP Recertification Audit

PR Newswire associated0

FDA Lifts Clinical Hold on NUZ-001

Pictured (L-R): Heidi co-founders Waleed Mussa, CFO; Dr. Thomas Kelly, CEO; and Yu Liu, CTO.

Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician

PR Newswire associated0

Why Travel for Wellness: ASICS Reveals 15 Minutes of Movement Can Boost Your Mood More Than a Week at a Wellness Retreat

BAT Announces 70% of Policy Experts Continue to Misidentify Nicotine as Primary Cause of Smoking-related Disease

EANM'25: Metabolically active visceral fat linked to aggressive endometrial cancer, new study reveals